Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Drug Reviewers And Legal Staff Among Those Called Back to US FDA, But Why?
Feb 24 2025
•
By
Sarah Karlin-Smith
The FDA is recalling more staff just one week after instituting layoffs.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from Pathways & Standards